ArticleAnnals of translational medicine2022

Efficacy and safety of original EGFR-TKI combined with bevacizumab in advanced lung adenocarcinoma patients harboring EGFR-mutation experiencing gradual progression after EGFR-TKI treatment: a single-arm study.

Jianlin Long et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.